Determination of the Serum Protein Binding of Oxycodone and Morphine Using Ultrafiltration

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Therapeutic Drug Monitoring

• Publication date

  1993-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00007691-199310000-00014PMID 8249052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Oxycodone Pharmacokinetics in Humans After Intravenous, Oral, and Rectal Administration

  1992cited by this paper
• The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

  1992cited by this paper
• The pharmacokinetics of oxycodone after intravenous injection in adults.

  1991cited by this paper
• Clinical pharmacokinetics of morphine.

  1991cited by this paper
• Quantitation of Oxycodone in Human Plasma Using High‐Performance Liquid Chromatography with Electrochemical Detection

  1991cited by this paper
• Disease-Induced Variations in Plasma Protein Levels Implications for Drug Dosage Regimens (Part I)

  1990cited by this paper
• Protein binding of nifedipine

  1986cited by this paper
• Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs.

  1986cited by this paper
• The plasma protein binding of basic drugs.

  1986cited by this paper
• Plasma Drug Binding: Implications for Anesthesiologists

  1986cited by this paper
• Free drug measurements: methodology and clinical significance.

  1985cited by this paper
• Alpha 1-acid glycoprotein and albumin in human serum bupivacaine binding.

  1985cited by this paper
• Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers.

  1985cited by this paper
• Plasma and tissue binding considerations in drug disposition.

  1983cited by this paper
• Normal metabolism of morphine in cirrhosis.

  1981cited by this paper
• Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling

  1979cited by this paper
• Morphine and phenytoin binding to plasma proteins in renal and hepatic failure

  1975cited by this paper
• Spuriously low plasma propranolol concentrations resulting from blood collection methods

  1975cited by this paper

• Exploring the Impact of CYP2D6 and UGT2B7 Gene-Drug Interactions, and CYP-mediated DDI on Oxycodone and Oxymorphone Pharmacokinetics using Physiologically-Based Pharmacokinetic Modelling and Simulation.

  2024cites this paper
• Nasal absorption of oxycodone predicted using a novel computational fluid dynamics-physiologically based pharmacokinetic model.

  2024cites this paper
• Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7

  2021cites this paper
• A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.

  2021cites this paper
• Electrochemical Detection of Morphine in Untreated Human Capillary Whole Blood

  2021cites this paper
• Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions.

  2020cites this paper
• Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone

  2019cites this paper
• Pharmacology of Opioids

  2018cites this paper
• A Multifaceted Analysis of Oxycodone Addiction

  2018cites this paper
• Morphine Binds Creatine Kinase B and Inhibits Its Activity

  2018influential citation
• PharmGKB summary: oxycodone pathway, pharmacokinetics

  2018cites this paper
• DARK Classics in Chemical Neuroscience: Morphine.

  2018cites this paper
• Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics

  2018cites this paper
• Analgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty

  2017cites this paper
• Professor Tess Cramond (1926–2015): Contributions to Anaesthesia and Pain Medicine

  2017cites this paper
• Oxycodone DETERx® ER Capsules: A Review in Severe, Chronic Pain

  2016cites this paper
• Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects

  2016cites this paper
• On-column entrapment of alpha1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography

  2016cites this paper
• The relationship between methylation and genes associated with opioid response in humans

  2016cites this paper
• Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.

  2015cites this paper
• A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.

  2015cites this paper
• Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model

  2014cites this paper
• Comparison of serum and lithium-heparinate plasma for the accurate measurements of endogenous and exogenous morphine concentrations.

  2012cites this paper
• Dose Conversion during Opioid Rotation from Continuous Intravenous Infusion of Morphine Hydrochloride to Oral Administration of Oxycodone Sustained-release Tablets

  2012cites this paper
• Metabolism of Oxycodone in Human Hepatocytes from Different Age Groups and Prediction of Hepatic Plasma Clearance

  2012influential citation
• Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients

  2012influential citation
• Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone.

  2012cites this paper
• Oxycodone/Ibuprofen Combination Tablet

  2012cites this paper
• Intra-articular injection of morphine to the horse: establishment of an in vitro–in vivo relationship.

  2011cites this paper
• Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo.

  2011cites this paper
• Pharmacokinetics of Oxycodone and Paracetamol in the Elderly. Clinical Pharmacokinetic Study on Orthopaedic Surgical Patients and Healthy Volunteers

  2011cites this paper
• Strong opioids in cancer pain : clinical and pharmacogenetic factors influencing an individual's response to morphine and oxycodone

  2010cites this paper
• Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients

  2010cites this paper
• Role of oxycodone and oxycodone/naloxone in cancer pain management

  2010cites this paper
• The in vitro and in vivo formation and potency of 6β-naltrexol, the major human metabolite of naltrexone.

  2010cites this paper
• Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry.

  2009cites this paper
• Blood–Brain Barrier Transport Helps to Explain Discrepancies in In Vivo Potency between Oxycodone and Morphine

  2008cites this paper
• Morphine in Children with Cancer

  2007cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 50 Pharmacokinetics and Pharmacodynamics of Oxycodone and Morphine with Emphasis on Blood-Brain Barrier Transport

  2007influential citation
• Transport Is Not Rate-Limiting in Morphine Glucuronidation in the Single-Pass Perfused Rat Liver Preparation

  2006cites this paper
• Cerebral kinetics of oxycodone in conscious sheep.

  2006cites this paper
• Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules*

  2006cites this paper
• Oxycodone/Ibuprofen combination tablet: a review of its use in the management of acute pain.

  2005cites this paper
• Pharmacological profile and clinical data in chronic pain management

  2005cites this paper
• The Pharmacokinetics of Oxycodone

  2005cites this paper
• The pharmacokinetics of oxycodone.

  2005cites this paper
• Pharmacodynamics and pharmacokinetics of high-dose oxycodone infusion during and after coronary artery bypass grafting.

  2004cites this paper
• Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy

  2003cites this paper
• HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡

  2001cites this paper
• Isolation, identification and synthesis of hydromorphone metabolites : analysis and antinociceptive activities in comparison to morphine

  1999cites this paper
• Comparison of the analgesic effects of intrabursal oxycodone and bupivacaine after acromioplasty.

  1999cites this paper
• Effect of drugs and cocaine metabolites on cocaine and cocaethylene binding to human serum in vitro.

  1997cites this paper
• The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

  1996cites this paper
• Calculating percentage prediction error: a user's note.

  1995cites this paper